SC 13D
Beneficial Ownership Report
Starling Oncology, Inc. Filed Acc 0001193125-21-336832
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-13 SCHEDULE 13G/A · Chernett Jorey 5.6%
- 2026-05-15 SCHEDULE 13D/A · M33 Growth I L.P. 4.94%
- 2026-03-16 SCHEDULE 13G/A · Chernett Jorey 10.2%
- 2026-01-15 SCHEDULE 13G · Chernett Jorey 5.2%
- 2025-11-20 SCHEDULE 13D/A · M33 Growth I LP 5.46%
- 2025-09-05 SCHEDULE 13D/A · M33 Growth I LP 9.79%
- 2025-06-24 SCHEDULE 13G/A · FOG Ventures Investments, LLC 0%
- 2025-04-23 SCHEDULE 13D/A · Ravi Sarin 4.7%
- 2025-03-28 SCHEDULE 13D/A · M33 Growth I LP 19.99%
- 2024-12-06 SCHEDULE 13G/A · FMR LLC 0.0%
Loading d254266dsc13d.htm…